GSDMD and neoplasm: Although wild-type Gsdmd expression attenuates tumor growth in immune-competent mice as noted before, anti-PD-1 administration further suppresses tumor progression and leads to a nearly invisible tumor burden at the experimental endpoints, which was not observed for D276A GSDMD-reconstituted tumors (Fig. 7b, c).